Table 2 Susceptibility of polymyxin-resistant CRKP strains to commonly used antibiotics (n = 112)

From: Increasing polymyxin resistance in clinical carbapenem-resistant Klebsiella pneumoniae strains in China between 2000 and 2023

Antibiotics

MIC50 (µg/mL)

MIC90 (µg/mL)

No. of isolates (%)

Susceptible

Resistant

Polymyxin B

>8

>8

0 (0%)

112 (100%)

Meropenem

128

>128

0 (0%)

112 (100%)

Ertapenem

>128

>128

0 (0%)

112 (100%)

Imipenem

64

>128

0 (0%)

111 (99.11%)

Cefepime

>64

>64

0 (0%)

112 (100%)

Ceftazidime

>128

>128

0 (0%)

112 (100%)

Cefotaxime

>128

>128

0 (0%)

112 (100%)

Cefmetazole

>128

>128

11 (9.82%)

99 (88.39%)

Aztreonam

>128

>128

1 (0.89%)

111 (99.11%)

Piperacillin-tazobactam

>256/4

>256/4

0 (0%)

112 (100%)

Cefoperazone-sulbactam

>256/128

>256/128

0 (0%)

112 (100%)

Ceftazidime-avibactam

1/4

4/4

104 (92.86%)

8 (7.14%)

Ciprofloxacin

>32

>32

4 (3.57%)

108 (96.43%)

Amikacin

>128

>128

32 (28.57%)

80 (71.43%)

Tigecycline

1

1

101 (90.18%)

11 (9.82%)